Multiplier AI Blog
Know How Data, AI, & Digital Marketing Can Help Pharma & Life Sciences
Data Privacy in Omnichannel Pharma Engagement: What You Must Get Right
Pharma engagement has entered a new phase where data sits at the center of every meaningful interaction. Understanding how healthcare professionals engage, what content they consume, when they respond, and how their preferences evolve is now essential for delivering relevant communication.
Designing a Pharma Customer Data Platform for HCP Engagement
Pharma companies do not suffer from a lack of HCP data. They suffer from disconnected HCP data. A Pharma Customer Data Platform solves this by unifying CRM interactions, digital engagement, event data, prescription insights, and external healthcare datasets into one actionable physician profile.
AI in Pharma Compliance: How to Scale Personalization Without Breaking the Rules
Pharma is entering a phase where personalization is no longer optional. Healthcare professionals expect communication that reflects their interests, their patients, and their context. Generic messaging is increasingly ignored. Engagement quality is now directly tied to relevance.
Using Patent and Regulatory Filing Data to Predict Competitor Moves Before They Reach the Market
Most pharma teams believe they are monitoring competitors closely. They track launches, analyze prescribing trends, review conference data, and listen to field feedback. All of this is important, but it focuses on what is already visible.
What to Do When a Competitor Launches in Your Therapeutic Area: A 30-Day AI-Powered Response Playbook
A competitor launch is one of those moments that exposes how prepared a pharma organization really is. Before the launch, every team says they are watching the market closely. Commercial leaders believe they have the right visibility. Field teams believe they know their accounts. Brand teams believe their message is clear.
Competitive Share of Voice in Pharma: How AI Tracks It Across Digital and Field Channels
Competitive share of voice pharma AI tracking starts from a simple observation: in pharma, market share is often treated as the ultimate measure of success because it reflects prescribing behavior, adoption rates, and commercial performance. However, market share is an outcome.
How AI Summarizes Clinical Conference Insights for Pharma Field Teams
AI clinical conference insights in pharma address one of the industry's most persistent operational gaps. Clinical conferences are among the most information-rich events in the pharma industry — they bring together new research, expert opinions, emerging data, and evolving treatment perspectives in one place.
Turning Prescribing Pattern Shifts Into Field Intelligence: A Practical Guide
Every pharma organization has access to prescribing data. It is one of the most valuable assets in commercial operations. It shows what doctors are doing, how treatments are being adopted, and how markets are evolving.
How to Monitor Competitor Brand Launches Before They Happen: An AI Approach
Monitor pharma competitor launch AI strategies exist because, in pharma, a competitor launch is not a surprise event. It is the result of years of clinical development, regulatory work, and commercial preparation. Yet despite this long timeline, many organizations still find themselves reacting rather than preparing.
Pharma Competitive Intelligence in the Age of AI: From Quarterly Reports to Real-Time Signals
Competitive intelligence has always been a critical function in pharma. Understanding what competitors are doing, how markets are shifting, and where opportunities exist has a direct impact on commercial success.
Patient-Centric vs HCP-Centric Omnichannel: Why You Need Both and How They Connect
The False Choice That Limits Most Pharma StrategiesThe debate over patient-centric vs HCP-centric omnichannel pharma engagement has shaped how most companies allocate budgets, build teams, and design campaigns. Some teams emphasize healthcare professionals as the primary audience, while others advocate for a more patient-focused approach.
The Rise of AI-Generated Pharma Content: Compliance, Quality, and What MLR Teams Need to Know
In most pharma organizations today, the biggest constraint is no longer data or distribution. It is content — and this is exactly where AI-generated pharma content is changing the equation. Teams have more channels than ever: email, field engagement, digital platforms, mobile messaging, and virtual interactions are all available, and the ability to reach healthcare professionals has expanded si